Financials ASICS Corporation OTC Markets

Stocks

ASCCY

US04521N1019

Footwear

Market Closed - OTC Markets 01:28:30 05/09/2026 am IST			5-day change	1st Jan Change
27.35 ^USD	+1.41%		-4.47%	+14.44%

14/08	Asics Corporation Announces Dividend of the Second Quarter End of Fiscal Year Ending December 31, 2026, Payable on August 20, 2026 and Revises Dividend Guidance for the Fiscal Year End of Fiscal Year Ending December 31, 2026	CI
14/08	Asics Corporation Revises Consolidated Earnings Guidance for the Fiscal Year Ending December 31, 2026	CI

Projected Income Statement: ASICS Corporation

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Net sales ¹	4,04,082	4,84,601	5,70,463	6,78,526	8,10,916	10,29,942	11,45,904	12,64,946
Change	-	19.93%	17.72%	18.94%	19.51%	27.01%	11.26%	10.39%
EBITDA ¹	35,996	50,002	70,719	1,21,353	1,68,442	2,23,968	2,48,508	2,72,478
Change	-	38.91%	41.43%	71.6%	38.8%	32.96%	10.96%	9.65%
EBIT ¹	21,945	34,002	54,215	1,00,111	1,42,519	1,94,586	2,19,801	2,44,928
Change	-	54.94%	59.45%	84.66%	42.36%	36.53%	12.96%	11.43%
Interest Paid ¹	-1,723	-2,662	-4,846	-5,427	-5,045	-981.5	-683.5	-968
Earnings before Tax (EBT) ¹	14,120	28,703	50,572	93,244	1,38,749	1,83,907	2,10,882	2,37,836
Change	-	103.28%	76.19%	84.38%	48.8%	32.55%	14.67%	12.78%
Net income ¹	9,402	19,887	35,272	63,806	98,719	1,27,651	1,45,411	1,63,356
Change	-	111.52%	77.36%	80.9%	54.72%	29.31%	13.91%	12.34%
Announcement Date	10/02/22	10/02/23	09/02/24	14/02/25	13/02/26	-	-	-

¹JPY in Million

Estimates

Fiscal Period: December	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	2024 Q2	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4	2026 Q1	2026 Q2	2026 Q3	2026 Q4	2027 Q1	2027 Q2	2027 Q3	2027 Q4
Net sales ¹	1,12,729	81,875	1,05,329	1,19,751	1,37,988	1,21,533	1,52,297	1,37,782	1,58,026	1,22,358	1,74,102	1,68,097	1,83,255	1,53,072	2,08,313	1,94,485	2,22,257	1,85,861	2,70,265	2,64,218	2,74,086	2,27,612	3,06,000	3,02,000	3,18,000	2,82,000
Change	-	-27.37%	28.65%	13.69%	15.23%	-11.92%	25.31%	-9.53%	14.69%	-22.57%	42.29%	-3.45%	9.02%	-16.47%	36.09%	-6.64%	14.28%	-16.38%	45.41%	-2.24%	3.73%	-16.96%	34.44%	-1.31%	5.3%	-11.32%
EBITDA ¹	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	53,197	22,625	68,588	68,037	70,700	31,475	-	-	-	-
Change	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-57.47%	203.15%	-0.8%	3.91%	-55.48%	-	-	-	-
EBIT ¹	11,792	-13,840	10,057	9,109	16,885	-2,049	22,120	11,490	22,195	-1,590	33,812	25,184	32,527	8,588	44,511	36,621	46,474	14,913	60,762	59,724	56,886	20,926	68,000	66,000	66,000	30,000
Change	-	-217.37%	172.67%	-9.43%	85.37%	-112.14%	1,179.55%	-48.06%	93.17%	-107.16%	2,226.54%	-25.52%	29.16%	-73.6%	418.29%	-17.73%	26.91%	-67.91%	307.44%	-1.71%	-4.75%	-63.21%	224.96%	-2.94%	0%	-54.55%
Charge d'intérêts	-428	-	-457	-	-737	-	-1,009	-	-1,253	-	-1,291	-	-1,364	-	-1,247	-	-1,274	-	-1,346	-	-	-	-	-	-	-
Earnings before Tax (EBT) ¹	10,082	-	10,943	7,558	15,079	-4,877	21,605	11,794	21,829	-4,656	33,062	24,996	34,015	1,171	43,382	37,349	45,807	12,211	61,869	-	57,800	400	-	-	-	-
Change	-	-	-	-30.93%	99.51%	-132.34%	543%	-45.41%	85.09%	-121.33%	810.09%	-24.4%	36.08%	-96.56%	3,604.7%	-13.91%	22.65%	-73.34%	406.67%	-	-	-99.31%	-	-	-	-
Net income ¹	6,723	-9,671	8,725	4,837	9,683	-3,358	16,310	8,486	15,484	-5,008	26,737	15,482	22,721	-1,134	31,647	21,959	32,708	12,405	46,569	35,602	37,450	7,690	48,900	43,500	44,800	15,200
Change	-	-243.85%	190.22%	-44.56%	100.19%	-134.68%	585.71%	-47.97%	82.47%	-132.34%	633.89%	-42.1%	46.76%	-104.99%	2,890.74%	-30.61%	48.95%	-62.07%	275.41%	-23.55%	5.19%	-79.47%	535.93%	-11.04%	2.99%	-66.07%
Announcement Date	05/11/21	10/02/22	11/05/22	12/08/22	11/11/22	10/02/23	10/05/23	08/08/23	10/11/23	09/02/24	10/05/24	13/08/24	08/11/24	14/02/25	15/05/25	13/08/25	12/11/25	13/02/26	13/05/26	14/08/26	-	-	-	-	-	-

¹JPY in Million

Estimates

Fiscal Period: December	2022 S1	2022 S2	2023 S1	2024 S1	2024 S2	2025 S1	2025 S2	2026 S1
Net sales ¹	2,25,080	2,59,521	2,90,079	3,42,199	3,36,327	4,02,798	4,08,118	5,34,483
Change	-	15.3%	11.77%	17.97%	-1.72%	19.76%	1.32%	30.96%
EBITDA	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-
EBIT ¹	19,166	14,836	33,610	58,996	41,115	81,132	61,387	1,20,486
Change	-	-22.59%	126.54%	75.53%	-30.31%	97.33%	-24.34%	96.27%
Charge d'intérêts ¹	-997	-	-2,244	-2,724	-	-2,439	-	-2,940
Earnings before Tax (EBT) ¹	18,501	-	33,399	58,058	35,186	80,731	58,018	1,11,666
Change	-	-	-	73.83%	-39.4%	129.44%	-28.13%	92.47%
Net income ¹	13,562	6,325	24,796	42,219	21,587	53,606	45,113	82,171
Change	-	-53.36%	292.03%	70.27%	-48.87%	148.33%	-15.84%	82.14%
Announcement Date	12/08/22	10/02/23	08/08/23	13/08/24	14/02/25	13/08/25	13/02/26	14/08/26

¹JPY in Million

Estimates

Forecast Balance Sheet: ASICS Corporation

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Net Debt ¹	14,175	72,415	18,112	-69,745	-13,738	-80,672	-1,33,146	-1,89,874
Change	-	410.86%	-74.99%	-485.08%	80.3%	-487.22%	-65.05%	-42.61%
Announcement Date	10/02/22	10/02/23	09/02/24	14/02/25	13/02/26	-	-	-

¹JPY in Million

Estimates

Cash Flow Forecast: ASICS Corporation

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
CAPEX ¹	9,415	10,570	15,882	24,114	16,191	28,732	30,437	31,896
Change	-	12.27%	50.26%	51.83%	-32.86%	77.46%	5.93%	4.79%
Free Cash Flow (FCF) ¹	38,979	-35,908	74,569	80,500	78,957	95,058	1,34,126	1,51,259
Change	-	-192.12%	307.67%	7.95%	-1.92%	20.39%	41.1%	12.77%
Announcement Date	10/02/22	10/02/23	09/02/24	14/02/25	13/02/26	-	-	-

¹JPY in Million

Estimates

Forecast Financial Ratios: ASICS Corporation

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Profitability
EBITDA Margin (%)	8.91%	10.32%	12.4%	17.88%	20.77%	21.75%	21.69%	21.54%
EBIT Margin (%)	5.43%	7.02%	9.5%	14.75%	17.58%	18.89%	19.18%	19.36%
EBT Margin (%)	3.49%	5.92%	8.87%	13.74%	17.11%	17.86%	18.4%	18.8%
Net margin (%)	2.33%	4.1%	6.18%	9.4%	12.17%	12.39%	12.69%	12.91%
FCF margin (%)	9.65%	-7.41%	13.07%	11.86%	9.74%	9.23%	11.7%	11.96%
FCF / Net Income (%)	414.58%	-180.56%	211.41%	126.16%	79.98%	74.47%	92.24%	92.59%
Profitability
ROA	6.53%	8.02%	11.4%	18.84%	25.2%	20.17%	21.15%	20.58%
ROE	6.9%	12.6%	18.8%	29.1%	38.84%	43.15%	36.82%	33.54%
Financial Health
Leverage (Debt/EBITDA)	0.39x	1.45x	0.26x	-	-	-	-	-
Debt / Free cash flow	0.36x	-2.02x	0.24x	-	-	-	-	-
Capital Intensity
CAPEX / Current Assets (%)	2.33%	2.18%	2.78%	3.55%	2%	2.79%	2.66%	2.52%
CAPEX / EBITDA (%)	26.16%	21.14%	22.46%	19.87%	9.61%	12.83%	12.25%	11.71%
CAPEX / FCF (%)	24.15%	-29.44%	21.3%	29.96%	20.51%	30.23%	22.69%	21.09%
Items per share
Cash flow per share ¹	32.04	49	70.65	116.8	173.5	171.2	216.3	248.4
Change	-	52.92%	44.2%	65.25%	48.59%	-1.31%	26.34%	14.84%
Dividend per Share ¹	6	10	16.25	20	28	40.67	48.08	54
Change	-	66.67%	62.5%	23.08%	40%	45.24%	18.24%	12.31%
Book Value Per Share ¹	199.5	232.9	279.4	325.6	383.2	486.2	621.8	773
Change	-	16.71%	20%	16.52%	17.68%	26.89%	27.89%	24.32%
EPS ¹	12.84	27.15	48.13	88.3	138.1	180.7	209	233.3
Change	-	111.37%	77.27%	83.46%	56.43%	30.8%	15.67%	11.66%
Nbr of stocks (in thousands)	7,32,167	7,32,677	7,32,945	7,15,737	7,08,624	7,08,911	7,08,911	7,08,911
Announcement Date	10/02/22	10/02/23	09/02/24	14/02/25	13/02/26	-	-	-